SCYNEXIS (SCYX) - Shares outstanding

Number of shares outstanding as of November 2024 : 48,511,656

According to SCYNEXIS's latest financial reports and stock price the company's current number of shares outstanding is 48,511,656. At the end of 2024 the company had 48,511,656 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for SCYNEXIS from 2020 to 2024

Shares Outstanding at the end of each year

Year	Shares Outstanding	Change
2024	48.51 M	1.29%
2023	47.89 M	0.82%
2022	47.5 M	78.47%
2021	26.61 M	150.45%
2020	10.62 M

Shares Outstanding for similar companies or competitors

Company	Shares Outstanding	differencediff.	Country
Galmed Pharmaceuticals GLMD	524,562	-98.92%	🇮🇱 Israel
KemPharm KMPH	34,494,702	-28.89%	🇺🇸 USA
Catalent CTLT	182,000,000	275.17%	🇺🇸 USA
Catalyst Pharmaceuticals CPRX	118,180,396	143.61%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

Number of shares outstanding for SCYNEXIS (SCYX)

Number of shares outstanding as of November 2024 : 48,511,656